Table 1 Demographic and clinical characteristics

Age (years)

49.4 ± 10.5

51.5 ± 9.5

47.0 ± 11.7

Race n, (%)

 White

13 (69%)

8 (80%)

5 (56%)

 Black

5 (26%)

2 (20%)

3 (33%)

 Other

1 (5%)

0 (0%)

1 (11%)

Ethnicity n, (%)

 Not hispanic

19 (100%)

10 (100%)

9 (100%)

Working status n, (%)

 Full time (at least 1 job)

12 (63%)

7 (70%)

5 (56%)

 Part time (no FT)

4 (21%)

2 (20%)

2 (22%)

 Other

3 (16%)

1 (10%)

2 (22%)

Household income n, (%)

 0–49,999

5 (26%)

3 (30%)

2 (22%)

 50,000–75,000

4 (21%)

3 (30%)

1 (11%)

 75,001–125,000

6 (32%)

1 (10%)

5 (56%)

 125,000+

4 (21%)

3 (30%)

1 (11%)

Education n, (%)

 HS/some college

4 (21%)

2 (20%)

2 (22%)

 Associates/Bachelors

8 (42%)

5 (50%)

3 (33%)

 Graduate school

7 (37%)

3 (30%)

4 (44%)

Partnered n, (%)

 Not partnered

5 (26%)

4 (40%)

1 (11%)

 Coupled

14 (74%)

6 (60%)

8 (89%)

Smoking status n, (%)

 Non or ex-smoker

16 (84%)

9 (90%)

7 (78%)

 Current smoker

3 (16%)

1 (10%)

2 (22%)

Site n, (%)

 CCC

6 (32%)

3 (30%)

3 (33%)

 CI

9 (47%)

5 (50%)

4 (44%)

Community

4 (21%)

2 (20%)

2 (22%)

Stage n, (%)

 1

4 (21%)

2 (20%)

2 (22%)

 2

10 (53%)

5 (50%)

5 (55%)

 3

5 (26%)

3 (30%)

2 (22%)

Tumor type n, (%)

 HR+ HER2+

6 (32%)

4 (40%)

2 (22%)

 HR+ HER2−

2 (11%)

1 (10%)

1 (11%)

 HR-HER2+

8 (42%)

4 (40%)

4 (44%)

 HR-HER2−

3 (16%)

1 (10%)

2 (22%)

Chemo n, (%)

 ACT

5 (26%)

2 (20%)

3 (33%)

 TCHP

9 (47%)

6 (60%)

3 (33%)

 ACTH

5 (26%)

2 (20%)

3 (33%)